Henry Schein (NASDAQ:HSIC) Given Hold Rating at Stifel Nicolaus

Key Points

• Henry Schein's stock received a "hold" rating from Stifel Nicolaus, with a revised price target of $75.00, reflecting a potential upside of 3.28% from the previous close.
• Multiple analysts have downgraded their ratings on Henry Schein, with a consensus rating of "hold" and a target price averaging $78.08.
• Henry Schein reported a quarterly earnings per share of $1.15, beating estimates, but its year-over-year revenue decreased by 0.1%.

Henry Schein (NASDAQ:HSIC - Get Free Report)'s stock had its "hold" rating reaffirmed by stock analysts at Stifel Nicolaus in a report released on Friday, MarketBeat.com reports. They presently have a $75.00 price objective on the stock, down from their previous price objective of $80.00. Stifel Nicolaus' target price indicates a potential upside of 6.48% from the stock's current price.

A number of other research analysts have also weighed in on HSIC. Piper Sandler cut their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 30th. Wells Fargo & Company cut their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research report on Monday, July 14th. Baird R W lowered shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Finally, Wall Street Zen lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Nine investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $78.08.

Henry Schein Stock Down 0.0%

HSIC traded down $0.03 during trading on Friday, reaching $70.43. The company had a trading volume of 400,372 shares, compared to its average volume of 1,713,106. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.38 and a quick ratio of 0.75. Henry Schein has a 12 month low of $60.56 and a 12 month high of $82.49. The business's fifty day moving average price is $71.88 and its 200 day moving average price is $71.39. The company has a market cap of $8.57 billion, a P/E ratio of 22.00, a PEG ratio of 2.31 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter in the previous year, the firm posted $1.10 earnings per share. The business's revenue was down .1% on a year-over-year basis. Equities analysts anticipate that Henry Schein will post 4.74 EPS for the current year.

Hedge Funds Weigh In On Henry Schein

Institutional investors and hedge funds have recently modified their holdings of the business. Investment Management Corp VA ADV acquired a new stake in Henry Schein during the fourth quarter worth about $32,000. Rakuten Securities Inc. bought a new position in shares of Henry Schein during the first quarter valued at $34,000. Steph & Co. bought a new position in shares of Henry Schein during the second quarter valued at $44,000. CX Institutional raised its stake in shares of Henry Schein by 107.3% during the second quarter. CX Institutional now owns 651 shares of the company's stock valued at $48,000 after acquiring an additional 337 shares during the last quarter. Finally, TD Private Client Wealth LLC raised its holdings in Henry Schein by 103.0% during the 2nd quarter. TD Private Client Wealth LLC now owns 668 shares of the company's stock worth $49,000 after purchasing an additional 339 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.